AmgenvsMBX Biosciences

AMGN and MBX stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$443.89

Value $239B

-3.07%
AMGN's page

MBX

MBX Biosciences, Inc.

$53.42

Value $2.5B

+0.60%
MBX's page

Amgen (AMGN) has a market value of $239B and MBX Biosciences (MBX) $2.5B. Over the last year, with dividends, AMGN moved +33.5% and MBX +108.6%. Dividend yield: AMGN 2.24%, MBX none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$239B

    MBX$2.5B

    AMGN is 94 times MBX

  • Revenue, 12 months

    AMGN$38.9B

    MBX–

  • Net income, 12 months

    AMGN$9.4B

    MBX-$145M

  • Operating margin

    AMGN32.4%

    MBX–

  • ROIC

    AMGN16.2%

    MBX-21.0%

    37.2 points apart

  • P/E

    AMGN25.5

    MBX–

  • Dividend yield

    AMGN2.2%

    MBX0.0%

    2.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+33.5%

MBX+108.6%

100150200250DecFebAprJunAugOct
Returns by period
PeriodAMGNWith dividendsMBXWith dividends
1 year since November 17, 2025+33.5%Price +29.9%+108.6%Price +108.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenMBXMBX Biosciences

Valuation

AMGNMBX
Valuation
Price$443.89$53.42
Market value$239B$2.5B
Enterprise value (EV)$280B$2.1B
P/E25.5–
P/E, 5-year median23.0–
P/B16.75.4
EV/EBIT22.2–
Free cash flow yield4.0%–

Results and growth

AMGNMBX
Results and growth
Revenue, 12 months$38.9B–
Net income, 12 months$9.4B-$145M
Free cash flow, 12 months$9.6B-$99M
Earnings per share, 12 months$17.25-$3.02
Revenue growth, year on year10.0%–
Revenue growth a year, past+7.6%over 5 years–
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNMBX
Margins and returns on capital
Gross margin70.9%–
Operating margin32.4%–
Net margin24.1%–
ROIC16.2%-21.0%
ROE87.8%-34.9%

Balance sheet

AMGNMBX
Balance sheet
Cash$13.2B$482M
Total debt$54.0B$3.3M
Net debt / EBITDA2.3–
Interest cover4.8×–

Dividends and buybacks

AMGNMBX
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–0.0%
Shareholder yield2.2%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or MBX

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or MBX Biosciences?

By market value, Amgen ($239B) is about 94.3 times MBX Biosciences ($2.5B), at today's prices.

How did AMGN and MBX stock do over the last 1 years?

Since November 17, 2025, AMGN's price moved +29.9% and MBX's +108.6%. With dividends: AMGN +33.5% (+33.5% a year), MBX +108.6% (+108.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or MBX?

The dividend yield at today's price is 2.24% for Amgen and none for MBX Biosciences. Over the last twelve months they paid $9.94 and – per share.

Which is the better investment, Amgen or MBX Biosciences?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.